Velan Capital Investment Management LP
Q3 2026 13F filing
Updated 6 days ago44 disclosed positions worth $104.7M
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | P PRAXIS PRECISION MEDICINES I | $22.3M | 76.6K | 21.30% | — |
| 2 | ? N/A IMMIX BIOPHARMA INC | $11.3M | 1.08M | 10.78% | — |
| 3 | T PROTARA THERAPEUTICS INC | $8.7M | 2.84M | 8.28% | — |
| 4 | ? N/A SUTRO BIOPHARMA INC | $8.2M | 510.0K | 7.84% | — |
| 5 | A ABIVAX SA | $6.5M | 65.6K | 6.20% | — |
| 6 | M MAPLIGHT THERAPEUTICS INC | $6.4M | 624.7K | 6.08% | — |
| 7 | A ANTERIS TECHNOLOGIES GLOBAL | $5.4M | 700.0K | 5.19% | — |
| 8 | ? N/A EDESA BIOTECH INC | $5.4M | 1.28M | 5.15% | — |
| 9 | A AVALO THERAPEUTICS INC | $5M | 324.5K | 4.75% | — |
| 10 | X XENCOR INC | $4.4M | 175.0K | 4.17% | — |
| 11 | E EVOMMUNE INC | $3.7M | 446.3K | 3.52% | — |
| 12 | E EUPRAXIA PHARMACEUTICALS INC | $3.2M | 352.0K | 3.06% | — |
| 13 | H HERON THERAPEUTICS INC | $2.7M | 8.75M | 2.62% | — |
| 14 | E EDGEWISE THERAPEUTICS INC | $1.4M | 34.3K | 1.33% | — |
| 15 | ? N/A REIN THERAPEUTICS INC | $1.4M | 1.70M | 1.30% | — |
| 16 | N NASUS PHARMA LTD | $1.3M | 359.4K | 1.27% | — |
| 17 | Q Q32 BIO INC | $992K | 120.0K | 0.95% | — |
| 18 | ? N/A INSPIREMD INC | $618K | 924.7K | 0.59% | — |
| 19 | P PROTAGONIST THERAPEUTICS INC | $521K | 3.7K | 0.50% | — |
| 20 | ? N/A AARDVARK THERAPEUTICS INC | $453K | 85.9K | 0.43% | — |
| 21 | N NURIX THERAPEUTICS INC | $379K | 16.0K | 0.36% | — |
| 22 | C CYTOMX THERAPEUTICS INC. | $326K | 120.0K | 0.31% | — |
| 23 | O OVID THERAPEUTICS INC | $324K | 130.0K | 0.31% | — |
| 24 | M MINERALYS THERAPEUTICS INC | $276K | 11.0K | 0.26% | — |
| 25 | Q REPLIMUNE GROUP INC | $265K | 20.0K | 0.25% | — |
| 26 | D PRECISION BIOSCIENCES INC | $250K | 40.0K | 0.24% | — |
| 27 | Z ZAI LAB LTD | $237K | 9.0K | 0.23% | — |
| 28 | B C4 THERAPEUTICS INC | $233K | 70.0K | 0.22% | — |
| 29 | M MACROGENICS INC | $232K | 60.0K | 0.22% | — |
| 30 | I IMMUNOME INC | $215K | 10.0K | 0.21% | — |
| 31 | ? N/A AN2 THERAPEUTICS INC | $213K | 40.0K | 0.20% | — |
| 32 | V VIRIDIAN THERAPEUTICS INC | $206K | 10.0K | 0.20% | — |
| 33 | C CORBUS PHARMACEUTICALS HLDGS | $205K | 30.0K | 0.20% | — |
| 34 | E ENANTA PHARMACEUTICALS INC | $198K | 15.0K | 0.19% | — |
| 35 | S SCYNEXIS INC | $198K | 40.0K | 0.19% | — |
| 36 | A ARTIVA BIOTHERAPEUTICS INC | $178K | 25.0K | 0.17% | — |
| 37 | R ROCKET PHARMACEUTICALS INC | $158K | 60.0K | 0.15% | — |
| 38 | L LYELL IMMUNOPHARMA INC | $147K | 15.0K | 0.14% | — |
| 39 | J JADE BIOSCIENCES INC | $141K | 10.0K | 0.13% | — |
| 40 | N NEUMORA THERAPEUTICS INC. | $137K | 230.0K | 0.13% | — |
| 41 | T TENAX THERAPEUTICS INC | $130K | 68.7K | 0.12% | — |
| 42 | L LARIMAR THERAPEUTICS INC | $105K | 33.0K | 0.10% | — |
| 43 | E EVOMMUNE INC | $83K | 10.0K | 0.08% | — |
| 44 | ? N/A KALARIS THERAPEUTICS INC | $72K | 25.0K | 0.07% | — |